MarketInOut Stock Screener Log In | Sign Up
 

Achieve Life Sciences Inc

IEX • Healthcare • Biotechnology • Quote as of 08/19/2026 15:59
Achieve Life Sciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization779.18 mln
Float87.71 mln
Earnings Date11/05/2026

Piotroski F-Score

1 / 9
Very weak

1-Year Forecast

13.83
Transformational upside

Relative Strength

98 / 100
Top performer

Debt / Equity

1.40
Elevated leverage

ROE

-221
Deeply negative

Dividend Yield

0.00%
No dividend

Business Description

Achieve Life Sciences is a pharmaceutical company based in Bothell, Washington, focused on helping people quit smoking. Its main product is cytisinicline, a natural compound derived from plants that works by targeting nicotine receptors in the brain to ease withdrawal symptoms. The company operates across North America and the United Kingdom, supported by partnerships with Sopharma AD and the University of Bristol for licensing and supply.

Key Fundamentals

EPS-1.66
ROE-221
ROIC-711
ROA-122
EBITDA, mln-50.86
EV / EBITDA-13.38
EV / EBIT-13.33

Financial Strength

Piotroski F-Score 1 / 9
1-Year Target Price13.83
Short Ratio10.69
Short % of Float15.94

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 27.65% 99 / 100   
1 Month 31.59% 96 / 100   
2 Months 42.33% 95 / 100   
6 Months 103% 98 / 100   
1 Year 221% 98 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us